Patch Testing in Symmetrical Drug-Related Intertriginous and Flexural Exanthema (Sdrife)

Clinical and Translational Allergy - United Kingdom
doi 10.1186/2045-7022-4-s3-p76
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Systemic Drug Related Intertriginous and Flexural Exanthema (SDRIFE) or Intertriginous Drug Eruption: A Matter of Semantics

Our Dermatology Online
2019English

Symmetrical Drug-Related Intertriginous and Flexural Exanthema Induced by Doxycycline

Cureus
2017English

Symmetrical Drug-Related Intertriginous and Flexural Exanthema Secondary to Epidermal Growth Factor Receptor Inhibitor Gefitinib

JAAD Case Reports
Dermatology
2020English

Patch Testing in Adverse Drug Reactions

2020English

Patch Testing in Drug Cutaneous Adverse Reactions: Value of the Extemporaneous Preparations

Clinical and Translational Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2014English

Patch Testing in Children and Adolescents With Contact Dermatitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

Patch Testing in Pediatric Patients With Atopic Disease

Journal of Allergy and Clinical Immunology
AllergyImmunology
2016English

Pruritic Papules in Multiple Intertriginous Areas

BMJ Case Reports
Medicine
2019English

894 Comprehensive Patch Testing in 22 Patients With Lichen Planopilaris

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy